vs

Side-by-side financial comparison of agilon health, inc. (AGL) and CHART INDUSTRIES INC (GTLS). Click either name above to swap in a different company.

agilon health, inc. is the larger business by last-quarter revenue ($1.6B vs $1.1B, roughly 1.5× CHART INDUSTRIES INC). CHART INDUSTRIES INC runs the higher net margin — 5.0% vs -12.0%, a 17.0% gap on every dollar of revenue. On growth, agilon health, inc. posted the faster year-over-year revenue change (3.1% vs -2.5%). CHART INDUSTRIES INC produced more free cash flow last quarter ($66.2M vs $-23.5M). Over the past eight quarters, CHART INDUSTRIES INC's revenue compounded faster (6.6% CAGR vs -1.1%).

agilon health, inc. is a U.S.-based healthcare company partnering with primary care providers to deliver value-based care solutions mainly for senior Medicare beneficiaries. It offers administrative support, clinical tools and risk management frameworks to help physicians improve patient outcomes and cut care costs, operating across over 20 U.S. states.

Oricon Inc. , established in 1999, is the holding company at the head of a Japanese corporate group that supplies statistics and information on music and the music industry in Japan and Western music. It started as Original Confidence Inc. , which was founded by Sōkō Koike in November 1967 and became known for its music charts. Oricon Inc. was originally set up as a subsidiary of Original Confidence and took over the latter's Oricon record charts in April 2002.

AGL vs GTLS — Head-to-Head

Bigger by revenue
AGL
AGL
1.5× larger
AGL
$1.6B
$1.1B
GTLS
Growing faster (revenue YoY)
AGL
AGL
+5.5% gap
AGL
3.1%
-2.5%
GTLS
Higher net margin
GTLS
GTLS
17.0% more per $
GTLS
5.0%
-12.0%
AGL
More free cash flow
GTLS
GTLS
$89.7M more FCF
GTLS
$66.2M
$-23.5M
AGL
Faster 2-yr revenue CAGR
GTLS
GTLS
Annualised
GTLS
6.6%
-1.1%
AGL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AGL
AGL
GTLS
GTLS
Revenue
$1.6B
$1.1B
Net Profit
$-188.9M
$53.6M
Gross Margin
33.3%
Operating Margin
-12.3%
11.6%
Net Margin
-12.0%
5.0%
Revenue YoY
3.1%
-2.5%
Net Profit YoY
-78.5%
-32.7%
EPS (diluted)
$1.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AGL
AGL
GTLS
GTLS
Q4 25
$1.6B
$1.1B
Q3 25
$1.4B
$1.1B
Q2 25
$1.4B
$1.1B
Q1 25
$1.5B
$1.0B
Q4 24
$1.5B
$1.1B
Q3 24
$1.5B
$1.1B
Q2 24
$1.5B
$1.0B
Q1 24
$1.6B
$950.7M
Net Profit
AGL
AGL
GTLS
GTLS
Q4 25
$-188.9M
$53.6M
Q3 25
$-110.2M
$-138.5M
Q2 25
$-104.4M
$76.1M
Q1 25
$12.1M
$49.5M
Q4 24
$-105.8M
$79.6M
Q3 24
$-117.6M
$69.0M
Q2 24
$-30.7M
$58.6M
Q1 24
$-6.1M
$11.3M
Gross Margin
AGL
AGL
GTLS
GTLS
Q4 25
33.3%
Q3 25
34.1%
Q2 25
33.6%
Q1 25
33.9%
Q4 24
33.6%
Q3 24
34.1%
Q2 24
33.8%
Q1 24
31.8%
Operating Margin
AGL
AGL
GTLS
GTLS
Q4 25
-12.3%
11.6%
Q3 25
-9.1%
-8.0%
Q2 25
-8.3%
15.7%
Q1 25
-1.4%
15.2%
Q4 24
-7.1%
17.0%
Q3 24
-9.2%
16.8%
Q2 24
-2.9%
16.1%
Q1 24
-0.4%
11.9%
Net Margin
AGL
AGL
GTLS
GTLS
Q4 25
-12.0%
5.0%
Q3 25
-7.7%
-12.6%
Q2 25
-7.5%
7.0%
Q1 25
0.8%
4.9%
Q4 24
-6.9%
7.2%
Q3 24
-8.1%
6.5%
Q2 24
-2.1%
5.6%
Q1 24
-0.4%
1.2%
EPS (diluted)
AGL
AGL
GTLS
GTLS
Q4 25
$1.06
Q3 25
$-3.23
Q2 25
$1.53
Q1 25
$0.94
Q4 24
$1.57
Q3 24
$1.33
Q2 24
$1.10
Q1 24
$0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AGL
AGL
GTLS
GTLS
Cash + ST InvestmentsLiquidity on hand
$173.7M
$366.0M
Total DebtLower is stronger
$35.0M
$3.7B
Stockholders' EquityBook value
$126.7M
$3.2B
Total Assets
$1.3B
$9.8B
Debt / EquityLower = less leverage
0.28×
1.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AGL
AGL
GTLS
GTLS
Q4 25
$173.7M
$366.0M
Q3 25
$171.7M
$399.2M
Q2 25
$171.4M
$342.3M
Q1 25
$136.9M
$296.2M
Q4 24
$188.2M
$308.6M
Q3 24
$148.2M
$310.2M
Q2 24
$109.5M
$247.4M
Q1 24
$111.7M
$191.9M
Total Debt
AGL
AGL
GTLS
GTLS
Q4 25
$35.0M
$3.7B
Q3 25
Q2 25
Q1 25
Q4 24
$3.8B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AGL
AGL
GTLS
GTLS
Q4 25
$126.7M
$3.2B
Q3 25
$306.1M
$3.2B
Q2 25
$408.9M
$3.4B
Q1 25
$500.3M
$3.0B
Q4 24
$471.0M
$2.8B
Q3 24
$574.9M
$3.0B
Q2 24
$676.6M
$2.7B
Q1 24
$689.3M
$2.7B
Total Assets
AGL
AGL
GTLS
GTLS
Q4 25
$1.3B
$9.8B
Q3 25
$1.6B
$9.8B
Q2 25
$1.7B
$9.7B
Q1 25
$1.9B
$9.3B
Q4 24
$1.7B
$9.1B
Q3 24
$2.1B
$9.5B
Q2 24
$2.2B
$9.3B
Q1 24
$2.3B
$9.2B
Debt / Equity
AGL
AGL
GTLS
GTLS
Q4 25
0.28×
1.13×
Q3 25
Q2 25
Q1 25
Q4 24
1.33×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AGL
AGL
GTLS
GTLS
Operating Cash FlowLast quarter
$-20.5M
$88.8M
Free Cash FlowOCF − Capex
$-23.5M
$66.2M
FCF MarginFCF / Revenue
-1.5%
6.1%
Capex IntensityCapex / Revenue
0.2%
2.1%
Cash ConversionOCF / Net Profit
1.66×
TTM Free Cash FlowTrailing 4 quarters
$-119.0M
$202.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AGL
AGL
GTLS
GTLS
Q4 25
$-20.5M
$88.8M
Q3 25
$-18.2M
$118.0M
Q2 25
$-35.1M
$145.9M
Q1 25
$-32.0M
$-60.0M
Q4 24
$16.4M
$281.4M
Q3 24
$-7.7M
$200.6M
Q2 24
$-18.7M
$116.1M
Q1 24
$-47.8M
$-95.1M
Free Cash Flow
AGL
AGL
GTLS
GTLS
Q4 25
$-23.5M
$66.2M
Q3 25
$-21.3M
$94.7M
Q2 25
$-38.3M
$122.0M
Q1 25
$-35.8M
$-80.1M
Q4 24
$13.2M
$260.9M
Q3 24
$-11.2M
$174.5M
Q2 24
$-22.0M
$88.0M
Q1 24
$-50.9M
$-141.2M
FCF Margin
AGL
AGL
GTLS
GTLS
Q4 25
-1.5%
6.1%
Q3 25
-1.5%
8.6%
Q2 25
-2.7%
11.3%
Q1 25
-2.3%
-8.0%
Q4 24
0.9%
23.6%
Q3 24
-0.8%
16.4%
Q2 24
-1.5%
8.5%
Q1 24
-3.2%
-14.9%
Capex Intensity
AGL
AGL
GTLS
GTLS
Q4 25
0.2%
2.1%
Q3 25
0.2%
2.1%
Q2 25
0.2%
2.2%
Q1 25
0.3%
2.0%
Q4 24
0.2%
1.9%
Q3 24
0.2%
2.5%
Q2 24
0.2%
2.7%
Q1 24
0.2%
4.8%
Cash Conversion
AGL
AGL
GTLS
GTLS
Q4 25
1.66×
Q3 25
Q2 25
1.92×
Q1 25
-2.64×
-1.21×
Q4 24
3.54×
Q3 24
2.91×
Q2 24
1.98×
Q1 24
-8.42×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AGL
AGL

Medical Services$1.6B100%
Other Operating$2.5M0%

GTLS
GTLS

Repair Service And Leasing Segment$330.4M31%
Heat Transfer Systems Segment$325.8M30%
Specialty Products Segment$259.5M24%
Transferred Over Time$94.4M9%
Transferred At Point In Time$69.5M6%

Related Comparisons